# A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

> **NCT01958957** · PHASE4 · COMPLETED · sponsor: **Jiangsu Kanion Pharmaceutical Co., Ltd** · enrollment: 6300 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Ginkgolides Meglumine Injection

## Key facts

- **NCT ID:** NCT01958957
- **Lead sponsor:** Jiangsu Kanion Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 6300 (ACTUAL)
- **Last updated:** 2014-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01958957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01958957, "A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01958957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*